Breast and Ovarian Cancer The identification of mutations in genes like BRCA1 and BRCA2 has significant implications. Women with these mutations can opt for preventive measures such as prophylactic mastectomy or oophorectomy. Additionally, targeted therapies like PARP inhibitors are available for those with these genetic alterations.
Endometriosis Genomic studies are uncovering genetic variants associated with endometriosis, paving the way for new diagnostic markers and potential therapeutic targets.
Uterine Fibroids Research into the genomics of uterine fibroids is helping to identify genetic factors that contribute to their development, leading to more targeted treatments and preventive strategies.
